CGS International

CGS International EBITDA per Share

The EBITDA per Share of CGS International (CGSI) as of Oct 31, 2026 is -0.63 USD.

EBITDA per Share

-0.63USD

YoY

21,976.76%

Last updated:

EBITDA per Share of CGS International is 2022 -0.63 USD. EBITDA per Share of CGS International was 2021 -0.00 USD. It decreases by 21,976.76% lower compared to the previous year.

The CGS International EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2015
-0.13 USD
Jan 1, 2016
-0.16 USD
Jan 1, 2017
-0.14 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.18 USD
Jan 1, 2020
-0.02 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.63 USD
The CGS International EBITDA per Share history
YEAREBITDA per ShareYoY
-0.63USD+21,976.76%
-0.00USD-87.41%
-0.02USD-87.26%
-0.18USD+10,938.88%
-0.00USD-98.87%
-0.14USD-10.78%
-0.16USD+22.06%
-0.13USD-39.43%
-0.22USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CGS International Stock analysis

What does CGS International do? CGS International, Inc. intends to provide TVs streaming advertisements for customers lining up outside nightclubs. The company also operates WAM, a sole-proprietorship focused on commercial agriproducts. WAM produces GENESIS 89 and GENESIS 89 Gold, formulated using minerals extracted from deep-ocean deposits combined with organic ingredients. GENESIS 89 contains over 80 trace minerals and serves as a soil amendment or foliar spray, while GENESIS 89 Gold is specifically designed for the cannabis industry and shipped as a concentrate to commercial growers. The primary buyers of GENESIS 89 and GENESIS 89 Gold are commercial growers in the cannabis industry, particularly for GENESIS 89 Gold. GENESIS 89 targets agricultural applications through soil amendment and foliar spray uses. The company's revenue streams come from the sale of these agriproducts, with GENESIS 89 Gold being tailored for cannabis growers who require specialized organic growth supplements. WAM, operating under CGS International, markets GENESIS 89 and GENESIS 89 Gold as premium organic growth supplements. The products are distributed as concentrates to commercial growers, emphasizing their natural mineral extraction process and organic formulation. The cannabis industry segment represents a key market for GENESIS 89 Gold, while broader agricultural sectors use GENESIS 89 for soil and plant health applications. CGS International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CGS International stock

EBITDA per Share of CGS International is -0.63 USD in 2022.

On Eulerpool you can find the complete historical development of EBITDA per Share CGS International since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CGS International

All Key Metrics — CGS International